Deborah Schofield

Professor

1994 …2022
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Professor Deborah Schofield is the inaugural Director of GenIMPACT: Centre for Economic Impacts of Genomic Medicine, in the Faculty of Business and Economics, Department of Economics, at Macquarie University. Professor Schofield has established herself is one of a handful of international leaders in the new field of economics of genomic medicine. She has been awarded more than $100 million in grant funding and has published over 200 papers. Although she has worked as an economist for two decades, Professor Schofield commenced her career as a Speech Pathologist running a paediatric clinic where she worked with children with developmental disorders and disabilities.  

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1995 2022

Critical illness in children: Can we afford to neglect the psychosocial risks? The impact, acceptability, and costeffectiveness of routine psychosocial assessment and stepped care for families of infants with heart disease

Kasparian, N., Schofield, D., Austin, M., Winlaw, D. S., Girgis, A., Sholler, G. F., Rose, D., Blake, J., Descallar, J., Leclair, K., Walker, K., Reilly, N. & Bryant, R.

22/10/1831/12/20

Project: Other

The primary care management and impact of osteoarthritis: learning from big data

Abbott, J. H., Dowell, T., Hefford, M., Wilson, R., Audas, R., Kvizhinadze, G., Darlow, B., Schofield, D. & Blakely, T.

1/10/1830/09/21

Project: Research

A Centre of Research Excellence in Adolescent Health: Making health services work for adolescents in a digital age. [Funded by NHMRC; Total Awarded; $2,500,000 APP1134894]

Steinbeck, K., Skinner, S. R., Sanci, L., Schofield, D., Brooks, F., Dawson, A., Ivers, R. Q., Perry, L., Liu, B., Collin, P., Third, A., Mooney-Somers, J., Straker, L., Baur, L. A., Kang, M., Hazell, P., Gibson, S., Eades, S. & Sawyer, S. M.

13/02/1831/10/22

Project: Research

EPIC-ID: The economic and social impacts of genetic sequencing for intellectual disability

Schofield, D., Roscioli, T., Mattick, J. S., Dinger, M., Kasparian, N., Barlow-Stewart, K., Cowley, M. J., Field, M., Buckley, M., Shrestha, R., Kirk, E., Petrie, D. & Sachdev, R.

1/02/1830/11/20

Project: Research

Research Outputs 1994 2019

Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness

Stark, Z., Schofield, D., Martyn, M., Rynehart, L., Shrestha, R., Alam, K., Lunke, S., Tan, T. Y., Gaff, C. L. & White, S. M., Jan 2019, In : Genetics in Medicine. 21, 1, p. 173-180 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Exome
Cost-Benefit Analysis
Quality-Adjusted Life Years
Costs and Cost Analysis
Disclosure

Economic costs of informal care for people with chronic diseases in the community: Lost income, extra welfare payments, and reduced taxes in Australia in 2015–2030

Schofield, D., Shrestha, R. N., Zeppel, M. J. B., Cunich, M. M., Tanton, R., Veerman, J. L., Kelly, S. J. & Passey, M. E., Mar 2019, In : Health and Social Care in the Community. 27, 2, p. 493-501 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Taxes
Caregivers
taxes
Patient Care
Chronic Disease

Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes

Schofield, D., Rynehart, L., Shrestha, R., White, S. M. & Stark, Z., 21 May 2019, In : Genetics in Medicine.

Research output: Contribution to journalArticleResearchpeer-review

Exome
Quality-Adjusted Life Years
Cost-Benefit Analysis
Economics
Health Care Costs

Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups

Carter, H. E., Schofield, D. & Shrestha, R., 1 Feb 2019, In : Open Heart. 6, 1, 8 p., e000939.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Cost of Illness
Cardiovascular Diseases
Mortality
Premature Mortality
Economics

The indirect costs of ischemic heart disease through lost productive life years for Australia from 2015 to 2030: results from a microsimulation model

Schofield, D., Cunich, M., Shrestha, R., Passey, M., Veerman, L., Tanton, R. & Kelly, S., 21 Jun 2019, In : BMC Public Health. 19, 1, 13 p., 802.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Myocardial Ischemia
Costs and Cost Analysis
Income Tax
Quality-Adjusted Life Years
Health

Activities 2015 2015

  • 1 Oral presentation

NCDMod: a microsimulation model exploring the economic impacts of obesity interventions in Australia

Sharyn Lymer (Speaker), Deborah Schofield (Speaker), Stephen Colagiuri (Speaker), Crystal Man Ying Lee (Speaker)
14 Oct 201515 Oct 2015

Activity: Talk or presentationOral presentation